Oral Miltefosine as Adjunctive Treatment for Recalcitrant Acanthamoeba Keratitis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Acanthamoeba keratitis is a rare, vision-threatening disease. Commercially available antiamoebics are poorly cysticidal and highly toxic, and therapeutic keratoplasties can be complicated by recurrence or graft failure. We aimed to discuss the use of oral miltefosine for treatment of recalcitrant Acanthamoeba keratitis.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Cornea

Title: Cornea

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1536-4798

ISSN (Print): 0277-3740

Publication date (Electronic): Jul 2019

Volume: 38

Issue: 7

Affiliations

[1 ] Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada.

Article

Publisher Item ID: 00003226-201907000-00021

DOI: 10.1097/ICO.0000000000001968

PubMed ID: 31170106

SO-VID: bb0fa1f6-7378-467d-b98d-097771bc8432

History

Data availability:

Comments

Comment on this article

scite_

Cited by 5

See all cited by